{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:20:49Z","timestamp":1775539249615,"version":"3.50.1"},"reference-count":35,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2015,10,5]]},"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The evidence of an association between calcium channel blockers (CCBs) and cancer is conflicting. The objective of the present study was to evaluate the risk of cancer (all, breast, prostate and colon cancers) in association with exposure to CCB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a population-based cohort study in patients exposed to CCBs from across the UK, using two comparison cohorts: (1) patients with no exposure to CCB (non-CCB) matched on age and gender and (2) unmatched patients unexposed to CCB and at least one other antihypertensive (AHT) prescription. Cancer incidence rates computed in the exposed and the two unexposed groups were compared using HRs and 95% CIs obtained from multivariate Cox regression analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 150\u2005750, 557\u2005931 and 156\u2005966 patients were included, respectively, in the CCB, non-CCB and AHT cohorts. Crude cancer incidence rates per 1000 person-years were 16.51, 15.75 and 10.62 for the three cohorts, respectively. Adjusted HRs (CI) for all cancers comparing CCB, non-CCB and AHT cohorts were 0.88 (0.86 to 0.89) and 1.01 (0.98 to 1.04), respectively. Compared to the AHT cohort, adjusted HRs (CI) for breast, prostate and colon cancer for the CCB cohort were 0.95 (0.87 to 1.04), 1.07 (0.98 to 1.16) and 0.89 (0.81 to 0.98), respectively. Analyses by duration of exposure to CCB did not show excess risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This large population-based study provides strong evidence that CCB use is not associated with an increased risk of cancer. The analyses yielded robust results across all types of cancer and different durations of exposure to CCBs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2015-009147","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T22:39:38Z","timestamp":1452292778000},"page":"e009147","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)"],"prefix":"10.1136","volume":"6","author":[{"given":"Lamiae","family":"Grimaldi-Bensouda","sequence":"first","affiliation":[{"name":"LA-SER, Paris, France"},{"name":"Conservatoire national des arts et m\u00e9tiers (CNAM), Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Klungel","sequence":"additional","affiliation":[{"name":"Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Kurz","sequence":"additional","affiliation":[{"name":"European Medicines Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C H","family":"de Groot","sequence":"additional","affiliation":[{"name":"Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana S","family":"Maciel Afonso","sequence":"additional","affiliation":[{"name":"Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie L","family":"de Bruin","sequence":"additional","affiliation":[{"name":"Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Pfizer Epidemiology, New York, New York, USA"},{"name":"Tulane University, New Orleans, Louisiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Rossignol","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"key":"2025101811471695000_6.1.e009147.1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jamainternmed.2013.9071","article-title":"Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years","volume":"173","author":"Li","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2025101811471695000_6.1.e009147.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e181"},{"key":"2025101811471695000_6.1.e009147.3","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(96)00219-1"},{"key":"2025101811471695000_6.1.e009147.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)04277-8"},{"key":"2025101811471695000_6.1.e009147.5","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(96)00186-0"},{"key":"2025101811471695000_6.1.e009147.6","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6"},{"key":"2025101811471695000_6.1.e009147.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-010-9590-x"},{"key":"2025101811471695000_6.1.e009147.8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11663"},{"key":"2025101811471695000_6.1.e009147.9","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-007-9135-0"},{"key":"2025101811471695000_6.1.e009147.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-005-9091-x"},{"key":"2025101811471695000_6.1.e009147.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)80084-0"},{"key":"2025101811471695000_6.1.e009147.12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.3.349"},{"key":"2025101811471695000_6.1.e009147.13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.0.CO;2-3"},{"key":"2025101811471695000_6.1.e009147.14","doi-asserted-by":"publisher","DOI":"10.1023\/B:CACO.0000036152.58271.5e"},{"key":"2025101811471695000_6.1.e009147.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(98)00176-9"},{"key":"2025101811471695000_6.1.e009147.16","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2343"},{"key":"2025101811471695000_6.1.e009147.17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1574884708666131111211802","article-title":"Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project","volume":"9","author":"Abbing-Karahagopian","year":"2014","journal-title":"Curr Clin Pharmacol"},{"key":"2025101811471695000_6.1.e009147.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03537.x"},{"key":"2025101811471695000_6.1.e009147.19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-79"},{"key":"2025101811471695000_6.1.e009147.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b81"},{"key":"2025101811471695000_6.1.e009147.21","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1151"},{"key":"2025101811471695000_6.1.e009147.22","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1557(200009\/10)9:5<359::AID-PDS507>3.0.CO;2-E"},{"key":"2025101811471695000_6.1.e009147.23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1472-6947-13-96","article-title":"A comparison of electronic health records at two major Peking University Hospitals in China to United States meaningful use objectives","volume":"13","author":"Lei","year":"2013","journal-title":"BMC Med Inform Decis Mak"},{"key":"2025101811471695000_6.1.e009147.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00157-0"},{"key":"2025101811471695000_6.1.e009147.25","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199813020-00002"},{"key":"2025101811471695000_6.1.e009147.26","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(05)62672-4","article-title":"Calcium-channel blockers and risk of cancer","volume":"349","author":"Jick","year":"1997","journal-title":"Lancet"},{"key":"2025101811471695000_6.1.e009147.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.13.1000"},{"key":"2025101811471695000_6.1.e009147.28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001000"},{"key":"2025101811471695000_6.1.e009147.29","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0095"},{"key":"2025101811471695000_6.1.e009147.30","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1001\/jamainternmed.2014.3867","article-title":"Breast cancer risk and use of calcium channel blockers using Swedish population registries","volume":"174","author":"Bergman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025101811471695000_6.1.e009147.31","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.29.5.1091"},{"key":"2025101811471695000_6.1.e009147.32","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G"},{"key":"2025101811471695000_6.1.e009147.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00447-7"},{"key":"2025101811471695000_6.1.e009147.34","doi-asserted-by":"publisher","DOI":"10.1002\/pds.910"},{"key":"2025101811471695000_6.1.e009147.35","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816080-00005"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2015-009147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:47:22Z","timestamp":1760813242000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2015-009147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,8]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1136\/bmjopen-2015-009147"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2015-009147","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}